This is exciting: A team at Massachusetts General Hospital led by Dr. Denise Faustman have is working on a vaccine for fibromyalgia. The cool thing is that it’s not even a new vaccine. The vaccine, called BcG, is 100 years old and it’s used around the world to prevent tuberculosis. Funded by a grant from Dr. Bruce Gilis, CEO of California biotech firm EpicGenetics, who believes that fibromyalgia is caused by protein abnormalities in white blood cells. They have a test called Fm/A that checks for these abnormalities. Dr. Faustman’s research shows that the BcG corrects these white blood cell abnormalities. If these protein abnormalities are indeed the cause of fibro, then it follows that the vaccine could provide relief.
Dr. Faustman is currently applying for FDA approval to start trials on the vaccine, and hopes begin recruiting patients to test the theory next year. Stay tuned.
Comments